logo
Plus   Neg
Share
Email

Integra Group Enters Into Multi-year Service Contract With JSC Yamal LNG

Integra Group (INTE.L) announced that it has signed a multi-year service contract with JSC Yamal LNG. The agreement covers development drilling services to be provided at the South-Tambeyskoye field on the Yamal peninsula on a day-rate basis. The contract has a duration from 2013 to 2018.

Integra's CEO Felix Lubashevsky said, "Long term contracts bring stability and predictability to our relationship with our customers and allow us to better plan our operations, investment and financing. This particular contract will provide for the stable utilization of our drilling crews for the next five years and will fully recover our planned investment of approximately US$30 million into brand new drilling equipment earmarked for this project. For our customer, such agreement secures access to drilling capacity in an environment of re-emerging deficit of spare OFS equipment and personnel."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT